Anti-Reflux Infant Formula Market Size to Reach 0.12 Billion by 2030 with 12 CAGR

Anti-Reflux Infant Formula Market Growth

The Business Research Company

The Business Research Company’s Anti-Reflux Infant Formula Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, September 17, 2026 /EINPresswire.com/ -- The anti-reflux infant formula market has been experiencing substantial growth recently as awareness about infant digestive health and specialized nutrition solutions continues to increase. This sector is evolving rapidly due to rising infant populations and advancements in formula technology that cater to specific health needs. Let’s explore the current market size, factors fueling growth, leading regions, and emerging trends shaping the future of this specialized infant nutrition market.

Current Market Size and Growth Projections for the Anti-Reflux Infant Formula Market
The anti-reflux infant formula market has shown impressive expansion in recent years. It is projected to grow from $74.24 billion in 2025 to $81.58 billion in 2026, representing a compound annual growth rate (CAGR) of 9.9%. This growth is largely driven by an increasing number of infant gastroesophageal reflux cases, greater public awareness of digestive disorders in infants, wider adoption of infant nutrition products, stronger pediatrician endorsements, and a rising demand for specialty formulas. Looking ahead, the market is expected to reach $117.14 billion by 2030, maintaining a solid CAGR of 9.5%. Factors contributing to this future expansion include ongoing development of clinically advanced formulas, rising demand for personalized nutrition, enhanced focus on infant gut health, growth in premium pediatric nutrition offerings, and increased investment in specialized infant healthcare.

Download a free sample of the anti-reflux infant formula market report:
https://www.thebusinessresearchcompany.com/sample_request?id=74007733&type=smp&name=Anti-Reflux%20Infant%20Formula%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=paid&utm_campaign=Sep_PR

Understanding Anti-Reflux Infant Formula and Its Purpose
Anti-reflux infant formula is a type of baby formula specially designed to minimize frequent spit-up and regurgitation by thickening the milk, making it easier for infants’ stomachs to retain. This product is typically recommended for babies diagnosed with gastroesophageal reflux (GER) and should only be used under the guidance of healthcare professionals to ensure proper care and safety.

Key Influences Driving Expansion in the Anti-Reflux Infant Formula Market
One major factor encouraging growth in this market is the rising number of infants worldwide. Infants, defined as children from birth up to about one year old, depend fully on caregivers for their nutritional and developmental needs. Increases in birth rates, supported by advancements in healthcare and improved living conditions, are expanding this population segment. Anti-reflux formulas assist infants by reducing regurgitation, which helps improve nutrient absorption and overall feeding comfort. For example, in 2024, England and Wales recorded 594,677 live births—a 0.6% increase compared to the previous year—according to the UK’s Office for National Statistics Census. This upward trend in infant numbers directly supports the growing demand for anti-reflux infant formulas.

View the full anti-reflux infant formula market report:
https://www.thebusinessresearchcompany.com/report/anti-reflux-infant-formula-market-report?utm_source=EINPresswire&utm_medium=paid&utm_campaign=Sep_PR

Rising Workforce Participation Among Mothers Boosting Demand
Another significant growth driver is the increasing number of working mothers balancing childcare and professional responsibilities. The need for convenient and efficient feeding options has become more important as dual-income households rise to meet higher living costs. Anti-reflux infant formulas ease feeding challenges by minimizing spit-up and discomfort, allowing working mothers to manage infant care more predictably amid busy schedules. Data from the US Bureau of Labor Statistics indicates that in 2023, 74% of mothers with children under 18 were employed—a rise of 1.1 percentage points from the prior year. This demographic shift continues to fuel the market’s expansion.

Greater Household Incomes Supporting Market Development
Increasing household incomes also contribute to the market’s growth by making premium and specialty infant nutrition products more accessible. Household income, which encompasses all earnings from members within a family, has been rising due to better employment opportunities and wage increases driven by industrial expansion and demand for skilled labor. Families with higher incomes are more able to afford specialized formulas designed to manage infant reflux and other digestive concerns. For instance, Statistics Iceland reported a 6.6% growth in household disposable income during the second quarter of 2024 compared to the same period in 2023. This financial improvement is enabling more families to invest in premium infant nutrition, supporting market growth.

Which Regions Lead and Which Are Poised for Rapid Growth?
By 2025, North America holds the largest share of the anti-reflux infant formula market. However, the Asia-Pacific region is forecast to experience the fastest growth during the upcoming years. The market analysis includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+ +44 7882 955267
email us here
Visit us on social media:
LinkedIn
Facebook
X